Peer AI Appoints David Florez as Vice President of Sales
Company adds executive sales leader as its customer base grows and
more companies move from AI pilots to production across their regulatory workflows
The appointment comes at a critical inflection point in the industry. Life sciences companies are quickly moving from AI pilots to scale production across their organizations. Research and development teams are increasingly adopting purpose-built AI that delivers measurable results in critical workflows. With growing demand in regulatory writing and the complexity of deploying transformational technology in highly regulated environments, Peer AI continues to put the team and leadership in place to help customers navigate this shift.
"AI implementation requires world-class technology and governance, validation, change management, and organizational alignment to drive change," said
Florez previously spent six years at Veeva Systems in a senior sales position, partnering with pharma and biotech leaders to implement cloud solutions across clinical, regulatory, and quality. His track record scaling adoption of mission-critical technology in highly-regulated industries will help accelerate Peer AI's go-to-market execution and expansion.
"Being a true partner means being where the industry is headed," said
The Peer AI platform deploys purpose-built, domain-specific AI agents combined with an intuitive AI-powered user interface that allows medical writers to apply their subject matter expertise at critical control points during documentation workflows. Top 20 pharmas and emerging biotechs are saving thousands of hours and improving quality of regulatory documents across pre-clinical, clinical, regulatory affairs, and chemistry, manufacturing, and controls (CMC).
Meet Florez and the Peer AI team at the upcoming DIA Regulatory Submissions, Information, and Document Management (RSIDM) Forum,
About Peer AI
Peer AI transforms regulatory documentation for life sciences companies through specialized AI agents that reduce drafting time. The agentic AI platform automates document creation across protocols, clinical study reports (CSR), narratives, investigational new drug (IND) applications, investigator's brochures (IBs), and plain language summaries, while medical writers maintain oversight and control. Peer AI serves pharmaceutical, biotech, and CRO organizations worldwide. The company is backed by top investors and led by industry veterans with decades of experience in AI and life sciences. For more information, visit getpeer.ai.
Media Contact:
Roger That Communications for Peer AI
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/peer-ai-appoints-david-florez-as-vice-president-of-sales-302669094.html
SOURCE Peer TechBio Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 35.5%! LONGi Once Again Breaks World Record for Crystalline Silicon-Perovskite Tandem Solar Cell Efficiency
- AMINA Becomes the First Regulated Bank to Integrate Leading Crypto Payments Network, Mesh
- Gabriel agrees to sell its European FurnMaster business to Leggett & Platt
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share